Form 4 for TNGX Tango Therapeutics, Inc.
Accepted 2026-05-05 19:46:28 ET · period of report 2026-05-01 · accession 0001193125-26-207094 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-05 19:46 | 2026-05-01 | TNGX | Gall Matthew | CFO | A - Grant | $0.00 | +40.0K | 40.0K | New | $0 |
| D | 2026-05-05 19:46 | 2026-05-01 | TNGX | Gall Matthew | CFO | A - Grant | $0.00 | +240.0K | 240.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | A | A | 40,000 | $0.00 | 40,000 | D | — | — | (F1) These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs shall vest over a three-year period at a rate of (i) 13,200 RSUs on or about May 10, 2027, (ii) 13,200 RSUs on or about May 10, 2028 and (iii) 13,600 RSUs on or about May 9, 2029, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-01 | A | A | 240,000 | $0.00 | 240,000 | D | $20.98 · — to 2036-05-01 | 240,000 Common Stock | (F2) This option shall vest and become exercisable over a four-year period, at a rate of 25% on April 15, 2027 with the remaining option shares vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. |